AI Models for Depressive Disorder Detection and Diagnosis: A Review
A comprehensive review of 55 studies examines AI methods for detecting and diagnosing Major Depressive Disorder, revealing trends toward graph neural networks for brain connectivity analysis, large language models for linguistic data, and multimodal fusion approaches. The survey highlights how AI can address the subjectivity in clinical depression diagnosis while advancing computational psychiatry through improved explainability and fairness.
This systematic review addresses a critical healthcare challenge: Major Depressive Disorder affects millions globally, yet diagnosis relies heavily on subjective clinical judgment rather than objective biomarkers. By synthesizing 55 studies across multiple AI methodologies and data modalities, the authors map an emerging field where computational approaches promise more standardized, scalable diagnostic tools. The research demonstrates that different data types require specialized architectures—graph neural networks excel at modeling brain connectivity patterns from neuroimaging data, while large language models capture nuanced linguistic markers in patient speech and text. The shift toward multimodal fusion represents recognition that depression manifests across multiple biological and behavioral dimensions simultaneously.
This work reflects broader healthcare digitalization trends where AI augments rather than replaces clinical expertise. The emphasis on explainability and algorithmic fairness signals growing awareness of AI risks in psychiatry, where biased models could misdiagnose vulnerable populations. For healthcare technology developers and digital therapeutics companies, this survey provides validation that AI-assisted depression detection remains a high-potential market segment. The field's maturation around standardized datasets and evaluation metrics reduces implementation barriers for researchers and commercial entities.
Investors in healthcare AI and mental health technology should monitor how these methodologies transition from academic research to clinical deployment. The convergence of improved models with regulatory pathways for digital health tools creates opportunities for companies developing objective diagnostic aids. Key challenges remain: validating these tools across diverse populations, integrating them into clinical workflows, and ensuring equitable access across socioeconomic backgrounds.
- →Graph neural networks and large language models are emerging as dominant approaches for different depression detection modalities
- →Multimodal fusion combining text, speech, and neuroimaging data represents the field's frontier for comprehensive patient assessment
- →Explainability and fairness considerations are becoming critical evaluation criteria alongside traditional accuracy metrics
- →Standardized public datasets and evaluation frameworks are accelerating research reproducibility and clinical translation
- →AI tools promise objective supplementary diagnostics but face challenges in real-world clinical integration and population equity